Search Results - "Antsiferov, M"

Unification of pathomorphological examination of patients with neuroendocrine tumors of the pituitary gland. Controversial issues of the new classification by Pronin, V. S., Antsiferov, M. B., Alekseeva, T. M., Pronin, E. V., Lapshina, A. M., Urusova, L. S.

“…The progressive improvement of the classification using modern analytical methods is an essential tool for the development of precise and personalized…”
Get full text

Analysis of the effectiveness of outpatient treatment of patients with diabetic foot by Komelyagina, E. Y., Antsiferov, M. B.

“…BACKGROUND: Diabetic foot syndrome is a late complication of diabetes mellitus and the main reason for non-traumatic amputations of the lower extremities in…”
Get full text

Selective screening of patients with associated somatic diseases as a method of early detection of acromegaly by Antsiferov, M. B., Pronin, V. S., Alekseeva, T. M., Ionova, O. A., Martynova, E. Y., Poteshkin, Yu. E., Chubrova, N. A., Zherebchikova, K. Y.

Get full text

Organization of outpatient care for patients with diabetes mellitus in the context of the COVID-19 pandemic using telemedicine technologies by Chichkova, V. V., Shapovalova, M. A., Chichkova, M. A., Antsiferov, M. B.

“…The COVID-19 pandemic had a serious impact on global health and showed that the current state of most health systems in the world was not ready for such an…”
Get full text

Impact of dapagliflozin on life expectancy in type 2 diabetes mellitus patients in routine practice by Antsiferov, M. B., Demidov, N. A., Tabakaev, N. A.

“…BACKGROUND : Value of diabetes mellitus as social and medical issue seems to be growing worldwide. High rates of concomitant cardiovascular disease represent…”
Get full text

Pharmacoepidemiological analysis of type 1 diabetes mellitus insulin therapy (According to the Moscow segment of the State Register of Diabetes Mellitus) by Antsiferov, M. B., Kantemirova, M. A., Demidov, N. A., Kalashnikova, M. F.

“…BACKGROUND : When developing programs for state reimbursement of the cost of medical services and medicines, when providing assistance to patients suffering…”
Get full text

Growth factors and their receptors in neuropathic diabetic foot ulcers of different durations by Komelyagina, E. Y., Antsiferov, M. B., Kogan, E. A., Zharkov, N. V.

“…BACKGROUND . Growth factors play a leading role in wound healing. Their deficiency in diabetic foot syndrome has been demonstrated in experimental studies,…”
Get full text

Erratum: Insufficiency/deficiency of vitamin B12 in patients in the endocrinological practice (Diabetes mellitus. 2024;27(3). doi: 10.14341/DM13181) by Mokrysheva, N. G., Shestakova, M. V., Ametov, A. S., Antsiferov, M. B., Bakulin, I. G., Vavilova, T. V., Galstyan, G. R., Demidova, T. Y., Dzgoeva, F. K., Karonova, T. L., Lukina, E. А., Mkrtumyan, A. M., Petunina, N. А., Ponomaryov, R. V., Suponeva, N. A., Sukhareva, O. Y., Shamkhalova, M. S.

“…An erratum on « Insufficiency/deficiency of vitamin B12 in patients in the endocrinological practice» by Natalya G. Mokrysheva, Marina V. Shestakova, Alexander…”
Get full text

Insufficiency/deficiency of vitamin B12 in patients in the endocrinological practice by Mokrysheva, N. G., Shestakova, M. V., Ametov, A. S., Antsiferov, M. B., Bakulin, I. G., Vavilova, T. V., Galstyan, G. R., Demidova, T. Y., Dzgoeva, F. K., Karonova, T. L., Lukina, E. A., Mkrtumyan, A. M., Petunina, N. A., Ponomaryov, R. V., Suponeva, N. A., Sukhareva, O. Y., Shamkhalova, M. S.

“…On March 20, 2024, an interdisciplinary meeting of the Expert Council on the current problem of B12 insufficiency/deficiency and the prevalence of this…”
Get full text

Prevalence of chronic kidney disease in patients with type 2 diabetes admitted to multidisciplinary hospitals: results of a prospective observational multicenter study (CREDO) by Antsiferov, M. B., Kotenko, O. N., Kobalava, Z. D., Demidova, T. Y., Markova, T. N., Tolkacheva, V. V., Morgunov, L. Y., Andreeva, A. V., Pashkova, E. Y., Khaziakhmetova, M. R., Samburova, E. S., Vedyashkina, S. G., Mkrtumyan, A. M., Petunina, N. А., Serebrov, А. N., Deeva, T. M., Karaeva, A. Y.

“…AIM: To assess the prevalence of chronic kidney disease (CKD), clinical and demographic characteristics and therapy profile in patients with type 2 diabetes…”
Get full text

Influence of type 2 sodium-glucose co-transporter inhibitors (dapagliflozin) on the indicators of total mortality in patients with type 2 diabetes (CARDIA-MOS study, Moscow) by Antsiferov, M. B., Demidov, N. A., Balberova, M. A., Lobanova, O. V., Mudrikova, I. G., Gusenbekova, D. G.

“…BACKGROUND: The widespread use in clinical practice of drugs with cardio- and nephroprotective properties, in particular, sodium-glucose cotransporter type 2…”
Get full text

A 10-year (1996-2005) prospective study of the incidence of Type 1 diabetes in Moscow in the age group 0-14 years by Pronina, E. A., Petraikina, E. E., Antsiferov, M. B., Duchareva, O.V., Petrone, A., Buzzetti, R., Pozzilli, P.

“…Aims  To provide data on the incidence of Type 1 diabetes (T1D) in Moscow, determined prospectively from 1996 to 2005 for a total of > 10 million subjects aged…”
Get full text

Guidelines on diagnostics and treatment of acromegaly (draft) by Przhiyalkovskaya, E. G., Mokrysheva, N. G., Troshina, E. A., Melnichenko, G. A., Dedov, I. I., Antsiferov, M. B., Astafieva, L. I., Bardymova, T. P., Belaya, Zh. E., Vagapova, G. R., Vorotnikova, S. Yu, Grigoriev, A. Yu, Grineva, E. N., Dzeranova, L. K., Ilovaiskaya, I. A., Kalinin, P. L., Lapshina, A. M., Lutsenko, A. S., Mamedova, E. O., Marova, E. I., Perepelova, M. A., Pigarova, E. A., Pronin, V. S., Rozhinskaya, L. Ya, Trunin, Yu. Yu, Shutova, A. S.

“…We recommend acromegaly to be ruled in all patients with characteristic changes in appearance (A3). In all patients without characteristic changes in…”
Get full text

Pancreatic exocrine insufficiency in diabetes mellitus by Shestakova, M. V., Maev, I. V., Ametov, A. S., Antsiferov, M. B., Bordin, D. S., Galstyan, G. R., Dzgoeva, F. K., Kucheryavyy, Y. A., Mkrtumyan, A. M., Nikonova, T. V., Pashkova, E. Y.

“…Diabetes is disease of both the endo- and exocrine parts of the pancreas. Pancreatic exocrine insufficiency (PEI) can occur in every 2–3 patients with diabetes…”
Get full text

Prevalence of heart failure among hospitalized patient with T2D: results of a prospective observational multicenter study (CREDO) by Antsiferov, M. B., Kobalava, Zh. D., Demidova, T. Y., Markova, T. N., Tolkacheva, V. V., Morgunov, L. Y., Andreeva, A. V., Pashkova, Е. Y., Khaziakhmetova, M. R., Samburova, E. S., Vedyashkina, S. G., Mkrtumyan, A. M., Petunina, N. А., Serebrov, A. N., Deeva, T. M., Karaeva, A. Y.

“…BACKROUND: Heart failure (HF) is in the first place in the structure of cardiovascular death in patients with type 2 diabetes mellitus (T2D). One of the…”
Get full text

Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes by Demidova, T. Yu, Lobanova, K. G., Perekhodov, S. N., Antsiferov, M. B., Oynotkinova, O. Sh

“…Aim. To assess the relationship between type 2 diabetes (T2D) and the course and outcomes of coronavirus disease 2019 (COVID-19), depending on clinical and…”
Get full text

Real World Effectiveness of fixed combination of glargine 100 U/ml and lixisenatide therapy in outpatients with Type 2 Diabetes: A Retrospective Cohort Study SOLO by Antsiferov, M. B., Demidov, N. A., Balberova, M. A., Safronova, T. I., Mishra, O. A., Magomedova, S. G.

“…Background: The effectiveness and safety of a fixed combination of insulin glargine 100 ME/ml and lixisenatide for treatment of patients with type 2 diabetes…”
Get full text

Prospects of finerenone use in Russian population of patients with chronic kidney disease and type 2 diabetes. Resolution of multidisciplinary. Advisory board by Shestakova, M. V., Dobronravov, V. A., Ametov, A. S., Antsiferov, M. B., Batyushin, M. M., Bobkova, I. N., Galstyan, G. R., Demidova, T. Y., Klimontov, V. V., Mkrtumyan, A. M., Petunina, N. A., Prokopenko, E. I., Chebotareva, N. V., Shamkhalova, M. S.

“…Chronic kidney disease (CKD) in patients with type 2 diabetes (T2D) is one of the most important medical and social problems associated with significant risks…”
Get full text

The advisory board resolution on the use of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes by Antsiferov, M. B., Galstyan, G. R., Demidova, T. Yu, Zilov, A. V., Markova, T. N., Mkrtumyan, А. M., Petunina, N. A., Khalimov, I. S., Shamkhalova, M. S., Shestakova, M. V.

“…Type 2 diabetes is characterized by increasing incidence and prevalence all-over the world. Current therapeutic management of type 2 diabetes is complex and is…”
Get full text

MULTIDISCIPLINARY TEAM APPROACH FOR DIABETIC FOOT PATIENTS IN AN OUT-PATIENT CLINIC by Komelyagina, E Yu, Volkovoy, A K, Sanbanchieva, N I, Zaichikova, M Fe, Maksimov, N V, Antsiferov, M B

“…To assess the effectiveness of multidisciplinary team approach in daily practice of diabetic foot. 376 diabetic patients (446 ulcers) treated in a diabetic…”
Get more information